English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Plus monthly

Global: Zendy Tools annual

Global: Zendy Tools monthly

Global: Zendy Free Plan

Cells programmed to traffic through lymph nodes dominate initial increases in total CD4(+) T cell numbers after highly active antiretroviral therapy (HAART) is begun for human immunodeficiency virus type 1 (HIV-1) infection. However, it is unknown whether this dominance continues throughout the first year of treatment. To examine this question, 10 subjects who had a positive response to HAART for 1 year were selected from a cohort of 20 who were receiving this treatment. Flow cytometry, which was used to characterize CD4(+) T cell subsets by immunophenotype, demonstrated that cells programmed to traffic through lymph nodes, irrespective of their memory or naive phenotype, continued to best account for increases in CD4(+) T cells, even 1 year after starting HAART. This suggests that, although this pool is preferentially depleted during HIV-1 infection, HAART allows for reaccumulation of these cells for at least 1 year. Furthermore, it suggests that phenotypic differences based on markers of lymphocyte trafficking may be more relevant for understanding HIV-1 pathogenesis than are naive and memory markers alone.

the journal of infectious diseases (online. university of chicago press)/the journal of infectious diseases

CD4<sup>+</sup>T Cells Programmed to Traffic to Lymph Nodes Account for Increases in Numbers of CD4<sup>+</sup>T Cells Up to 1 Year after the Initiation of Highly Active Antiretroviral Therapy for Human Immunodeficiency Virus Type 1 Infection

CD4+T Cells Programmed to Traffic to Lymph Nodes Account for Increases in Numbers of CD4+T Cells Up to 1 Year after the Initiation of Highly Active Antiretroviral Therapy for Human Immunodeficiency Virus Type 1 Infection

CD4⁺T Cells Programmed to Traffic to Lymph Nodes Account for Increases in Numbers of CD4⁺T Cells Up to 1 Year after the Initiation of Highly Active Antiretroviral Therapy for Human Immunodeficiency Virus Type 1 Infection